Connable Office Inc’s Bio-Techne TECH Stock Holding History

Connable Office Inc’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,892	Closed	-$256K	–	239
2026 Q1	$256K	Hold	4,892	–	–	0.03%	196
2025 Q4	$288K	Hold	4,892	–	–	0.03%	197
2025 Q3	$272K	Buy	+4,892	New	+$262K	0.03%	190

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Connable Office Inc's TECH Position: Q2 2026 in Review

Connable Office Inc sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 4,892 shares — an estimated $256K sold.

Connable Office Inc first reported a position in TECH in Q3 2025 and held it in 3 quarters. The position peaked at $288K in Q4 2025. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Connable Office Inc reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
Connable Office Inc sold 4,892 Bio-Techne shares in Q2 2026, an estimated $256K.
Connable Office Inc first reported a position in Bio-Techne in Q3 2025 and held it in 3 quarters.
Connable Office Inc's Bio-Techne position peaked at $288K in Q4 2025.
597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Connable Office Inc's 13F filing for Q2 2026, filed 3 Aug 2026.